CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- Open-market buys, last 90 days
- $6,396,312
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$6,396,312. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-08-31 | Jebsen Michael B Chief Financial Officer | Grant or award | +14,938 | $1.84 | $27K | 27,623 |
| 2012-08-15 | Jebsen Michael B Chief Financial Officer | Returned to the company | +279 | $1.07 | $299 | 12,685 |
| 2012-07-01 | Jebsen Michael B Chief Financial Officer | Returned to the company | +279 | $1.57 | $438 | 12,964 |
| 2012-06-01 | Jebsen Michael B Chief Financial Officer | Returned to the company | +279 | $2.01 | $561 | 13,243 |
| 2012-05-15 | Jebsen Michael B Chief Financial Officer | Returned to the company | +279 | $1.78 | $497 | 13,522 |
| 2012-05-01 | Chatfield William A. Director | Grant or award | +18,961 | $1.78 | $34K | 42,289 |
| 2012-05-01 | RALLIS CHRIS A Director | Grant or award | +18,680 | $1.78 | $33K | 25,773 |
| 2012-05-01 | DiTonno Anthony A Director | Grant or award · Incentive Stock Options | +25,391 | $1.78 | $45K | 35,200 |
| 2012-05-01 | BLANCK RONALD R Director | Grant or award | +18,961 | $1.78 | $34K | 43,479 |
| 2012-05-01 | Jebsen Michael B Chief Financial Officer | Grant or award | +8,600 | $1.78 | $15K | 13,801 |
| 2012-04-15 | Jebsen Michael B Chief Financial Officer | Returned to the company | +307 | $2.35 | $721 | 5,201 |
| 2012-03-15 | Jebsen Michael B Chief Financial Officer | Returned to the company | +309 | $2.69 | $831 | 5,508 |
| 2012-02-15 | Jebsen Michael B President and CFO | Returned to the company | +309 | $2.00 | $618 | 5,817 |
| 2012-01-15 | Jebsen Michael B Chief Financial Officer | Returned to the company | +309 | $1.43 | $442 | 6,126 |
| 2011-12-15 | Jebsen Michael B Chief Financial Officer | Returned to the company | +279 | $1.91 | $533 | 6,435 |
| 2011-11-15 | Jebsen Michael B Chief Financial Officer | Returned to the company | +279 | $2.11 | $589 | 6,714 |
| 2011-11-01 | BLANCK RONALD R Director | Grant or award | +9,538 | $2.11 | $20K | 17,028 |
| 2011-10-14 | Jebsen Michael B Chief Financial Officer | Shares withheld for taxes | −279 | $2.09 | $583 | 6,993 |
| 2011-10-14 | Klein Gerald L Chief Medical Officer | Shares withheld for taxes | −243 | $2.09 | $508 | 13,542 |
| 2011-09-12 | Jebsen Michael B Chief Financial Officer | Shares withheld for taxes | −279 | $2.28 | $636 | 7,272 |
Page 12 of 16 · 316 trades